Literature DB >> 29396850

Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort.

Fleur Cohen-Aubart1,2, Jean-François Emile3, Fabrice Carrat2,4,5, Zofia Helias-Rodzewicz3, Valérie Taly6, Frédéric Charlotte2,7, Philippe Cluzel2,8, Jean Donadieu9, Ahmed Idbaih10, Stéphane Barete11, Zahir Amoura1,2, Julien Haroche1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29396850     DOI： 10.1002/ajh.25055

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  28 in total

Review 1.  Erdheim-Chester disease: a rapidly evolving disease model.

Authors:  Francesco Pegoraro; Matthias Papo; Valerio Maniscalco; Frédéric Charlotte; Julien Haroche; Augusto Vaglio
Journal:  Leukemia       Date:  2020-06-26       Impact factor: 11.528

Review 2.  Tumor mutational burden and other predictive immunotherapy markers in histiocytic neoplasms.

Authors:  Gaurav Goyal; Denise Lau; Alison M Nagle; Robert Vassallo; Karen L Rech; Jay H Ryu; Caroline J Davidge-Pitts; W Oliver Tobin; Matthew J Koster; N Nora Bennani; Mithun V Shah; Minetta C Liu; Ronald S Go
Journal:  Blood       Date:  2019-01-29       Impact factor: 22.113

Review 3.  Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.

Authors:  Matthias Papo; Fleur Cohen-Aubart; Ludovic Trefond; Adeline Bauvois; Zahir Amoura; Jean-François Emile; Julien Haroche
Journal:  Curr Oncol Rep       Date:  2019-05-21       Impact factor: 5.075

Review 4.  Erdheim-Chester Disease: a Concise Review.

Authors:  Matthias Papo; Jean-François Emile; Thiago Trovati Maciel; Pierre Bay; Alistair Baber; Olivier Hermine; Zahir Amoura; Julien Haroche
Journal:  Curr Rheumatol Rep       Date:  2019-12-05       Impact factor: 4.592

5.  Histiocytic disorders: insights into novel biology and implications for therapy of Langerhans cell histiocytosis and Erdheim-Chester disease.

Authors:  Kenneth McClain
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

6.  The unique burden of rare cancer caregiving: caregivers of patients with Erdheim-Chester disease.

Authors:  Allison J Applebaum; Laura C Polacek; Leah Walsh; Anne S Reiner; Kathleen Lynch; Stephanie Benvengo; Justin Buthorn; Thomas M Atkinson; Jun J Mao; Katherine S Panageas; Eli L Diamond
Journal:  Leuk Lymphoma       Date:  2020-02-24

7.  Erdheim-Chester disease with asymmetric talus involvement: A case report.

Authors:  Qin Xia; Cheng Tao; Ke-Wei Zhu; Wei-Ye Zhong; Peng-Lin Li; Yi Jiang; Min-Zhi Mao
Journal:  World J Clin Cases       Date:  2020-02-06       Impact factor: 1.337

8.  Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.

Authors:  Ankush Bhatia; Vaios Hatzoglou; Gary Ulaner; Raajit Rampal; David M Hyman; Omar Abdel-Wahab; Benjamin H Durham; Ahmet Dogan; Neval Ozkaya; Mariko Yabe; Kseniya Petrova-Drus; Katherine S Panageas; Anne Reiner; Marc Rosenblum; Eli L Diamond
Journal:  Neuro Oncol       Date:  2020-07-07       Impact factor: 12.300

9.  Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1.

Authors:  Jérôme Razanamahery; Eli L Diamond; Fleur Cohen-Aubart; Karl-Heinz Plate; Giota Lourida; Frederic Charlotte; Zofia Hélias-Rodzewicz; Gaurav Goyal; Ronald S Go; Ahmet Dogan; Omar Abdel-Wahab; Benjamin Durham; Neval Ozkaya; Zahir Amoura; Jean-Francois Emile; Julien Haroche
Journal:  Haematologica       Date:  2019-05-23       Impact factor: 9.941

Review 10.  MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.

Authors:  Rikhia Chakraborty; Omar Abdel-Wahab; Benjamin H Durham
Journal:  Cold Spring Harb Perspect Med       Date:  2021-05-03       Impact factor: 6.915
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.